NovoLog Mix 70/30 100 [iU]/mL

NovoLog Mix 70/30 100 [iU]/mL is a pre-mixed insulin aspart suspension for subcutaneous use. It combines rapid-acting and intermediate-acting insulin to help manage blood glucose levels. This medication is designed for convenient administration, supporting diabetes care routines.

NovoLog Mix 70/30 100 [iU]/mL is used to control high blood sugar in adults and children with diabetes. This insulin aspart suspension is typically prescribed for those requiring both rapid and intermediate-acting insulin effects. It is often used in diabetes management to help regulate blood glucose levels throughout the day and night.

Common effects of NovoLog Mix 70/30 100 [iU]/mL may include localized reactions at the injection site, such as redness or swelling. Some users may experience hypoglycemia, characterized by symptoms like sweating, dizziness, or confusion. These effects vary among individuals and should be monitored.

Handle NovoLog Mix 70/30 100 [iU]/mL with care, ensuring it is stored properly to maintain its effectiveness. Always check the expiration date and inspect the suspension for any changes in appearance before use. Follow healthcare provider instructions for administration to minimize risks.

NovoLog Mix 70/30 100 [iU]/mL may interact with certain medications, including oral hypoglycemic agents and other drugs affecting blood sugar levels. Alcohol consumption can also influence its effects. Always consult a healthcare provider about potential interactions before starting this medication.